Siliceous Or Calcareous Material (e.g., Clay, Earth, Etc.) Patents (Class 514/770)
  • Patent number: 10809543
    Abstract: 3D glasses include an absorptive layer in a single lens of the glasses. The absorptive layer may be specifically tailored for spectral separation characteristics of a 3D filter portion of the lens. The absorptive layer may be combined with, and work in conjunction with, interference layers of a lens while also operating separately as an absorber. The absorptive layer may include biometric variations and/or positive runout. The absorptive layer may selectively absorb more of one color than other colors. A balancing absorber may be included in an opposite eye channel.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: October 20, 2020
    Assignee: Dolby Laboratories Licensing Corporation
    Inventors: Barret Lippey, Martin J. Richards
  • Patent number: 10758565
    Abstract: The present invention provides compositions comprising amorphous calcium carbonate (ACC), suitable to being administered by inhalation, and methods for their use in treating ACC-responsive diseases and conditions. Further provided are ACC compositions suitable for buccal or sublingual administration.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: September 1, 2020
    Assignee: AMORPHICAL LTD.
    Inventors: Yosef Ben, Yigal Dov Blum
  • Patent number: 10391484
    Abstract: Inventive concepts disclosed herein are directed to a capillary tube and a force assisted sample ejection mechanism. The capillary tube may be at least one of dissolvable or breakable. The force assisted sample ejecting mechanism releasing at least part of the sample of the first liquid from the capillary tube by at least one of abruptly shaking the capillary tube at least once or breaking the capillary tube.
    Type: Grant
    Filed: June 11, 2015
    Date of Patent: August 27, 2019
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: David J. Ledden, Janine A. Cox
  • Patent number: 9993535
    Abstract: A method of treating sarcopenia comprises immunizing a subject in need thereof against AGE-modified proteins or peptides of a cell. Immunizing a subject includes administering a vaccine that comprises an AGE antigen. Vaccines against AGE-modified proteins or peptides contain an AGE antigen, an adjuvant, optional preservatives and optional excipients.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: June 12, 2018
    Assignee: Siwa Corporation
    Inventor: Lewis S. Gruber
  • Patent number: 9951194
    Abstract: An iron oxide containing effect pigment, and methods for producing and using the same are discussed. The iron oxide containing effect pigment may include an iron oxide coating in direct contact with a particulate substrate, which may have high levels of hematite, magnetite, or maghemite; and low amounts of toxic metals. A method for producing the pigment may include chemical vapor deposition of iron pentacarbonyl onto a particulate substrate. The iron oxide containing effect pigments may be incorporated into compositions, such as cosmetics.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: April 24, 2018
    Assignee: BASF CORPORATION
    Inventors: Juergen Walker, Gabe Uzunian, Raimund Schmid, Aron Wosylus, Christoph Schwidetzky
  • Patent number: 9549563
    Abstract: An energy tablet and method of manufacturing the same that successfully masks the bitter taste of caffeine which has precluded popularity of chewable energy tablets in the past.
    Type: Grant
    Filed: October 24, 2012
    Date of Patent: January 24, 2017
    Assignee: KickAss Candy LLC
    Inventor: Todd Stutzman
  • Patent number: 9173925
    Abstract: The invention refers to an oral pharmaceutical tableted dosage form which comprises a mixture of: a) granules comprising ferrimannitol-ovalbumin (FMOA) and at least an intragranular pharmaceutical acceptable excipient including a binder; and b) extragranular pharmaceutical excipients including a filler and a binder; which may be obtained by wet-granulation and compression.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: November 3, 2015
    Assignee: Tedee Meiji Farma, S.A.
    Inventors: Ana Isabel Torres-Suarez, Daniel Filipe Tavares Da Silva Fernandes, Maria Esther Gil Alegre
  • Publication number: 20150139964
    Abstract: A buffered body fluid expander solution, in which the buffer is a physiologically acceptable buffer that is not an inorganic phosphate buffer, comprises calcium ions and magnesium ions at a concentration ratio of 5:1 to 1:1. The solutions are useful for the manufacture of medicaments and blood volume expanders, for treating hypovolemia or for treating the loss of extracellular and interstitial fluid in subjects suffering with burns, for treating respiratory and/or metabolic acidosis in a subject, for perfusion of the abdominal cavity during peritoneal dialysis of a subject with acute renal failure or an acute toxicity condition, for preventing and/or ameliorating reperfusion injury, and for delivering a therapeutic, test and/or synergistic agent to a subject, including a biological agent, such as at least one stem cell, peptide or genomic derived protein.
    Type: Application
    Filed: November 13, 2014
    Publication date: May 21, 2015
    Inventor: Douglas REES
  • Publication number: 20150140049
    Abstract: The present invention relates to a cosmetic and/or dermatological composition comprising, in a physiologically acceptable medium: a) at least some hydrophobic aerogel particles, b) at least some silicaparticles, c) at least one particle that absorbs sebum, the said composition comprising at least one aqueous phase. The invention also relates to a process for making the skin matt and/or for reducing its shine.
    Type: Application
    Filed: June 21, 2013
    Publication date: May 21, 2015
    Inventors: Patricia Pierre, Eric Lheureux
  • Patent number: 9023896
    Abstract: The invention provides a biodegradable drug-eluting particle useful for the delivery of diagnostic or therapeutic agents. In certain embodiments, the drug-eluting particle of the invention comprises a biodegradable porous silicon body, a reservoir formed within the porous silicon body having at least one opening to an exterior of the body, wherein the reservoir contains a therapeutic or diagnostic agent, and an agent-permeable seal disposed over the at least one opening. The invention further provides a method for treating a patient to obtain a desired local or systemic physiological or pharmacological effect comprising administering a sustained release drug delivery particle of the invention. The invention also provides methods of fabricating a drug-eluting particle for releasing therapeutic agents.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: May 5, 2015
    Assignee: pSivida US, Inc.
    Inventors: Paul Ashton, Hong Guo, Jianbing Chen, Leigh Canham
  • Patent number: 9023398
    Abstract: Provided is a method for increasing the solubility of a poorly-soluble substance used in pharmaceutical products, veterinary pharmaceutical products, quasi-drugs, cosmetic products, food products, agricultural chemicals, and the like, without using large amounts of additives. This is a method for improving aqueous solubility, which comprises coating the surface of the particle of a poorly-soluble substance used in pharmaceutical products, veterinary pharmaceutical products, quasi-drugs, cosmetic products, food products, agricultural chemicals, and the like, with microparticles of a calcium compound such as calcium phosphate or calcium carbonate.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: May 5, 2015
    Assignee: Kabushiki Kaisha Sangi
    Inventors: Shuji Sakuma, Keiichiro Kikukawa, Ryosuke Miyasaka
  • Publication number: 20150118310
    Abstract: Provided is an organic-inorganic hybrid composite of a polymerized cyclic nitroxide radical compound and inorganic nanoparticles. Such a composite is capable, for example, of maintaining a stable nanoparticle shape in gastric fluid, and can be used by itself or as a carrier for delivery of another drug to the intestines.
    Type: Application
    Filed: February 6, 2013
    Publication date: April 30, 2015
    Inventors: Yukio Nagasaki, Yutaka Ikeda, Toru Yoshitomi, Tatsuya Yaguchi, Mayo Yamashita, Md. Amran Hossain, Tomoki Yoshinari, Atsushi Ueda, Aki Hirayama
  • Patent number: 9017702
    Abstract: A formulation includes one or more active ingredients of poor water solubility for medical or non-medical use in the rearing of animals. The formulation is suitable for administration to the animals via their drinking water. It exhibits superior stability. The formulation comprises an active ingredient, a thickener combination and water, wherein the thickener combination comprises at least one thickener selected from the following groups A, B, C and D: (A) cellulose derivatives, such as methyl cellulose, sodium carboxy methyl cellulose, (B) non-cellulosic polysaccharide thickeners such as xanthan gums, Arabic gum, (C) cross-linked polyacrylic acid polymers, (D) hydrocolloidal hydrated silicates.
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: April 28, 2015
    Assignee: KRKA, D.D., Novo Mesto
    Inventors: Denise Leskovar, Franc Vrecer, Andrejka Kramar, Ivanka Kolenc, Ivan Gobec, Helena Princ
  • Patent number: 9006295
    Abstract: This invention discloses a process for stabilizing an aqueous mineral preparation comprising a step of adding at least one aldehyde-containing and/or aldehyde-releasing and/or phenolic and/or isothiazoline biocide to said aqueous mineral preparation.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: April 14, 2015
    Assignee: Omya International AG
    Inventors: Nicola Di Maiuta, Patrick Schwarzentruber
  • Patent number: 9000051
    Abstract: The present invention relates mainly to a cosmetic composition and in particular a composition for making up and/or caring for keratin material and more particularly the skin and/or the lips, including at least one supramolecular polymer and a filler with an oil uptake of greater than or equal to 1.5 ml/g.
    Type: Grant
    Filed: May 25, 2011
    Date of Patent: April 7, 2015
    Assignee: L'Oreal
    Inventors: Charlotte Feltin, Gaelle Brun
  • Publication number: 20150094679
    Abstract: A lotion composition is provided. The lotion composition can comprise a) about 0.1% to about 90%, by weight, of a microcrystalline wax; b) about 0.1% to about 25%, by weight, of POE-4 monolaurate; c) about 0.1% to about 50%, by weight, of POE-8 monostearate; and d) a carrier.
    Type: Application
    Filed: December 8, 2014
    Publication date: April 2, 2015
    Inventors: Robert Ya-lin Pan, Debora Christine Ebert, Peter Christopher Ellingson, Raphael Warren
  • Publication number: 20150073058
    Abstract: This invention discloses a process for stabilising an aqueous mineral preparation comprising a step of adding at least one aldehyde-containing and/or aldehyde-releasing and/or phenolic and/or isothiazoline biocide to said aqueous mineral preparation.
    Type: Application
    Filed: November 14, 2014
    Publication date: March 12, 2015
    Applicant: Omya International AG
    Inventors: Nicola Di Maiuta, Patrick Schwarzentruber
  • Publication number: 20150073476
    Abstract: The present invention relates to compositions comprising shape memory polymer (SMP) materials and uses thereof. Particularly, although not exclusively, the present invention relates to biocompatible shape memory polymer (SMP) materials and uses thereof in the medical field.
    Type: Application
    Filed: October 5, 2012
    Publication date: March 12, 2015
    Inventors: Malcolm Brown, Horacio Montes de Oca Balderas, Michael Andrew Hall, Alan William Bull, David Franklin Farrar, Philip Caton-Rose, Philip David Coates, Glen Thompson, Michael Martyn, Ian MacMillan Ward, Mark James Bonner, Peter John Hine, Paul Unwin, Robin Anthony Chivers, Michael Woodhead
  • Patent number: 8962036
    Abstract: Disintegrable preparations of lanthanum carbonate prepared by co-precipitation, facilitating the manufacture of oral pharmaceutical dosage forms such as tablets, capsules, powders, granules, and sprinkles, and the use of such dosage forms to treat subjects with hyperphosphatemia are disclosed.
    Type: Grant
    Filed: January 21, 2010
    Date of Patent: February 24, 2015
    Assignee: Mylan Pharmaceuticals Inc.
    Inventors: Andrea Blum Works, John Twist, Okey Noe
  • Publication number: 20150038592
    Abstract: The invention comprises a cosmetic and/or dermatological preparation based on water-in-oil emulsions, comprising at least two W/O emulsifiers and at least one oil having a spreadability value of more than 600 mm2/10 min.
    Type: Application
    Filed: February 12, 2013
    Publication date: February 5, 2015
    Inventors: Stephanie Von Der Fecht, Svenja Lena Moellgaard, Petra Koch, Isabel Balcke
  • Publication number: 20150005393
    Abstract: The present invention provides an iron oxide-coated layered silicate pigment that has no interference color, strongly exhibits the color inherent in iron oxide, and is excellent in gloss. The pigment of the present invention is an iron oxide-coated layered silicate pigment comprising a layered-silicate plate particle as base, and an iron oxide coated on the plate particle; wherein the iron oxide does not coat the surface portion of the plate particle or the iron oxide is localized on the edge portion rather than the surface portion of the plate particle. As the iron oxide, at least one kind selected from black iron oxide (Fe3O4) and red iron oxide (Fe2O3) can be used preferably. As the layered silicate, a mica-group layered silicate can be used preferably. The iron oxide-coated layered silicate pigment of the present invention can be incorporated into cosmetic preferably.
    Type: Application
    Filed: January 23, 2013
    Publication date: January 1, 2015
    Inventors: Masahiro Abiko, Ryuichi Seike, Tomohiro Hoshino
  • Publication number: 20150004205
    Abstract: The invention generally relates to surfaces having a protein-resistant hydrogel layer and methods for preparing a protein-resistant hydrogel layer on a surface. The protein-resistant hydrogel layer is formed by a protein-crosslinked water soluble polymer that is contacted with a surface to form a thin protein-resistant hydrogel layer on the surface.
    Type: Application
    Filed: June 18, 2014
    Publication date: January 1, 2015
    Inventors: Donald Elbert, Megan Kaneda, Evan Scott, Brad Wacker
  • Publication number: 20140370063
    Abstract: A subject matter of the present invention is a composition for topical application comprising hydrophobic silica aerogel particles and at least one emulsifying silicone elastomer. Another subject matter of the invention is a method for the cosmetic treatment of keratinous substances which consists in applying, to the keratinous substances, a composition as defined above, and also the use of this composition in the cosmetic or dermatological field and in particular for caring for, protecting and/or making up the skin of the body or face or for caring for the hair. The composition of the invention makes it possible to improve the sensory properties of cosmetic compositions provided in the anhydrous or emulsified form by making possible more complete absorption, without a greasy or unpleasant residual film on the skin.
    Type: Application
    Filed: February 5, 2013
    Publication date: December 18, 2014
    Inventor: Raluca Lorant
  • Patent number: 8906968
    Abstract: This invention discloses a process for stabilizing an aqueous mineral preparation comprising a step of adding at least one aldehyde-containing and/or aldehyde-releasing and/or phenolic and/or isothiazoline biocide to said aqueous mineral preparation.
    Type: Grant
    Filed: December 6, 2010
    Date of Patent: December 9, 2014
    Assignee: Omya International AG
    Inventors: Nicola Di Maiuta, Patrick Schwarzentruber
  • Patent number: 8900602
    Abstract: Disclosed is an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity. The orally rapidly disintegrating tablet, which has a good texture and taste, an appropriate hardness, and good disintegrating properties, can be produced by using a composition, which is prepared by dispersing, by spray-drying, an inorganic excipient and starch(es) in complex particles composed of mannitol and xylitol, in an orally rapidly disintegrating tablet.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: December 2, 2014
    Assignee: Fuji Chemical Industry Co., Ltd.
    Inventors: Keiichi Fujiwara, Tadashi Fukami, Haruka Koizumi
  • Publication number: 20140348887
    Abstract: A stable, aqueous composition containing a crosslinked, nonionic, amphiphilic polymer capable of forming a yield stress fluid in the presence of a surfactant is disclosed. The yield stress fluid is capable of suspending insoluble materials in the form of particulates and/or droplets requiring suspension or stabilization.
    Type: Application
    Filed: September 13, 2012
    Publication date: November 27, 2014
    Applicant: Lubrizol Advanced Materials, Inc.
    Inventors: Shui-Jen Raymond Hsu, Krishnan Chari, Wei-Yeih Yang, Prachur Bhargava, Murat Kadir
  • Publication number: 20140341954
    Abstract: Disclosed are methods of preparing stable O/W emulsions by particle adsorption via electrostatic interaction, and stable emulsions prepared by particle adsorption via electrostatic interaction. Compositions and products comprising the emulsions are also disclosed. Emulsions may be stable over an extended period of time at room temperature.
    Type: Application
    Filed: May 17, 2013
    Publication date: November 20, 2014
    Inventors: Vance BERGERON, Jean-Thierry SIMONNET, Florence LEVY, Aurelie LAFUMA, Stephane SANTUCCI
  • Patent number: 8889196
    Abstract: Described herein are dental composites comprising amorphous calcium phosphate nanoparticles and methods of making and using the same. The dental composites display increased Ca and PO4 release, improved mechanical properties, and improved antibacterial properties. Anti-bacterial agents, such as quaternary ammonium salts or silver-containing nanoparticles may be included in the composites.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: November 18, 2014
    Assignee: University of Maryland, Baltimore
    Inventor: Huakun Xu
  • Publication number: 20140335033
    Abstract: A consumer product comprises silane-modified oil comprising a hydrocarbon chain selected from the group consisting of: a saturated oil, an unsaturated oil, and mixtures thereof; and at least one hydrolysable silyl group covalently bonded to the hydrocarbon chain. The consumer product further comprises a perfume.
    Type: Application
    Filed: May 8, 2014
    Publication date: November 13, 2014
    Applicant: The Procter & Gamble Company
    Inventors: Rajan Keshav PANANDIKER, Beth Ann SCHUBERT, John August WOS, Luke Andrew ZANNONI, Nathan Ray Whitely
  • Publication number: 20140336274
    Abstract: The present invention is directed to a process for producing inorganic particulate material, the material obtainable by such process, a modified release delivery system comprising the material and the use of the material for the administration of a bioactive agent.
    Type: Application
    Filed: April 25, 2012
    Publication date: November 13, 2014
    Applicant: MERCK PATENT GMBH
    Inventors: Mario Maio, Eugenia Breininger, Karin Cabrera Perez, Ulrich Lang, Benjamin Peters, Thomas Puchert, Christoph Saal, Michael Schulz
  • Publication number: 20140335034
    Abstract: A consumer product comprises silane-modified oil comprising a hydrocarbon chain selected from the group consisting of: a saturated oil, an unsaturated oil, and mixtures thereof; and at least one hydrolysable silyl group covalently bonded to the hydrocarbon chain. The consumer product further comprises a preservative.
    Type: Application
    Filed: May 8, 2014
    Publication date: November 13, 2014
    Applicant: The Procter & Gamble Company
    Inventors: Rajan Keshav PANANDIKER, Beth Ann SCHUBERT, John August WOS, Luke Andrew ZANNONI, Nathan Ray Whitely
  • Patent number: 8883221
    Abstract: Micronutrient combination product, wherein the micronutrient combination product comprises zeaxanthin, lutein, zinc and copper.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: November 11, 2014
    Assignee: Bausch & Lomb Incorporated
    Inventors: Guenter Bellmann, Gudrun Claus-Herz
  • Patent number: 8883860
    Abstract: A method for purifying diatomaceous earth, whose natural colloidal structure is retained, which includes preparing a suspension of diatomaceous earth in a liquid wherein diatomaceous earth is insoluble, separating diatomaceous earth from the suspension, treating diatomaceous earth with an inorganic or organic acid, heat-treating the thus obtained product at a temperature not higher than 300° C., subjecting the product obtained to oxidative treatment and drying the purified product.
    Type: Grant
    Filed: October 12, 2011
    Date of Patent: November 11, 2014
    Assignees: Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag, ONP Holdings SE
    Inventors: Endre Mikulásik, Tamás Spaits, Kálmán Nagy, Gyula Lukács, Imre Markovits, Krisztina Fodorné Kocsmár, Livia Gregorné Boros, Tamás Mórász, László Szlávik, Máté Hudák, Gyöngyi Heréb, Réka Eszter Puskás, Zoltán Varga, Imre Kapui, György Clementis, Gábor Attila Bacher, Beatrix Bánkövi, Gitta Kiss, Ottó Albrecht
  • Publication number: 20140323589
    Abstract: The invention relates to a method for the preparation of composite silica alcogels, aerogels and xerogels, comprising i) providing a reaction mixture comprising at least the following: silane reagent, base catalyst, gelation retarding additive, aqueous/organic solvent mixture, guest particle, ii) agitating the reaction mixture as necessary and sufficient until achieving the viscosity where the spontaneous movement of the guest particles does not occur anymore; and iii) shaping the material obtained to a desired shape during or after step ii); then iv) drying, if desired The method according to the invention is also useful in continuous manufacturing technology, and the invention provides an apparatus for applying the method. The invention further provides novel composite silica alcogels, aerogels or xerogels obtainable by the method according to the invention.
    Type: Application
    Filed: October 26, 2012
    Publication date: October 30, 2014
    Applicant: Debreceni Egyetem
    Inventors: István Lázár, István Fábián
  • Publication number: 20140302159
    Abstract: The present invention relates to a composition for topical application, comprising at least one aqueous phase, at least one superabsorbent polymer and at least one lamellar or platelet-shaped matting mineral filler. A subject of the invention is also a cosmetic treatment process for keratin materials, which consists in applying to the keratin materials a composition as defined above, and also the use of this composition in the cosmetic or dermatological field, and in particular for caring for, protecting and/or making up bodily or facial skin, or for haircare. The composition according to the invention has both a matt appearance throughout all the steps of its use, from the appearance of the product up to the finished skin, and a comfortable sensation throughout its use, from the application to the total penetration of the product.
    Type: Application
    Filed: December 17, 2012
    Publication date: October 9, 2014
    Inventors: Laure Fageon, Raluca Lorant
  • Publication number: 20140303261
    Abstract: The present invention relates to an adhesive composition applicable to skin comprising a base polymer comprising at least one homopolymer and/or copolymer and silica. This invention also relates to a medical adhesive device including such adhesive composition.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 9, 2014
    Applicant: Euromed Inc.
    Inventors: Ravi Ramjit, Shridhar G. Gangolli
  • Publication number: 20140287014
    Abstract: This invention includes malleable, biodegradable, fibrous compositions for application to a tissue site in order to promote or facilitate new tissue growth. One aspect of this invention is a fibrous component that provides unique mechanical and physical properties. The invention may be created by providing a vessel containing a slurry, said slurry comprising a plurality of natural or synthetic polymer fibers and at least one suspension fluid, wherein the polymer fibers are substantially evenly dispersed and randomly oriented throughout the volume of the suspension fluid; applying a force, e.g., centrifugal, to said vessel containing said slurry, whereupon said force serves to cause said polymer fibers to migrate through the suspension fluid and amass at a furthest extent of the vessel, forming a polymer material, with said polymer material comprising polymer fibers of sufficient length and sufficiently viscous, interlaced, or interlocked to retard dissociation of said polymer fibers.
    Type: Application
    Filed: January 20, 2014
    Publication date: September 25, 2014
    Inventors: Timothy A. Ringeisen, William Christopher Wattengel
  • Publication number: 20140271565
    Abstract: The present invention provides a highly-sintered fluorapatite glass-ceramic comprising a high Ca/Al or Sr/Al mole-ratio, that possesses a microstructure that induces apatite/bone deposition.
    Type: Application
    Filed: November 8, 2013
    Publication date: September 18, 2014
    Applicant: University of Iowa Research Foundation
    Inventors: Isabelle Denry, Julie Holloway
  • Publication number: 20140272013
    Abstract: Disclosed herein are embodiments of a composition for use in forming films or coatings that prevent damage in foodstuffs, including plants, fruits, and vegetables. The disclosed compositions comprise a cellulose nanomaterial and can further comprise a nanoscale mineral compound and one or more additional components. Also disclosed are films or coatings made using the disclosed compositions, as well as methods for making the disclosed compositions and methods for using the disclosed compositions.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: State of Oregon acting by and through the State Board of Higher Education on behalf of Oregon Stat
    Inventors: Yanyun Zhao, John Simonsen, George Cavender, Jooyeoun Jung, Leslie H. Fuchigami
  • Publication number: 20140271872
    Abstract: Disclosed herein are novel methods of treating diseases, novel dosage forms, and novel methods of modulating the pharmacokinetics of active ingredients.
    Type: Application
    Filed: March 11, 2014
    Publication date: September 18, 2014
    Applicant: Patheon Inc.
    Inventors: Anh Thu Thi Pham, Akaash Kumari Singh, Stefan Proniuk
  • Publication number: 20140276484
    Abstract: Clay composite sheets, mats, films or membranes without polymers. Methods of preparing clay composite sheets, mats, films or membranes without using polymers in the method. Methods of using clay composite sheets, mats, films or membranes prepared without using polymers. Antimicrobial dressing having organo-modified clay product. Transdermal delivery of drugs using organo-modified clay product and methods.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicant: Materials Modification Inc
    Inventors: Kausik Mukhopadhyay, Krishnaswamy Kasthuri Rangan, Tirumalai Srinivas Sudarshan
  • Publication number: 20140248350
    Abstract: The present invention includes pH dependent, dry film coating compositions containing calcium silicate for use on orally-ingestible substrates such as tablets and the like. The film coating compositions can be applied as an aqueous suspension either directly to a substrate or after the substrate has been coated with a subcoat. In preferred aspects, the polymer is either an enteric or reverse-enteric polymer. Methods of preparing the dry film coatings, methods of preparing corresponding aqueous suspensions, methods of applying the coatings to substrates and the coated substrates themselves are also disclosed.
    Type: Application
    Filed: February 25, 2014
    Publication date: September 4, 2014
    Applicant: BPSI Holdings, LLC.
    Inventors: George REYES, Charles R. CUNNINGHAM, Thomas P. FARRELL, Cara YOUNG
  • Publication number: 20140242016
    Abstract: The present invention relates to non-aqueous emulsions stabilised by silica particles and to processes for making them. The invention further comprises: a particle stabilized oil-in-polar (o/polar o/p) emulsion comprising: a) a dispersed oil phase, b) a continuous polar phase substantially free of water, c) a particulate solid which is a silica particle dispersant possessing surface silanol groups (SiOH) sufficient to stabilize the emulsion, and where the emulsion is substantially free of emulsifiers, surfactants; and wherein the oil phase (a) is dispersed as discontinuous droplets in the polar phase (b); the silica particle dispersant (c) is absorbed on the surface of the oil phase (a); and the silica particle dispersant (c) is partially wetted by the polar phase (b).
    Type: Application
    Filed: February 21, 2014
    Publication date: August 28, 2014
    Applicant: Stiefel Laboratories, Inc.
    Inventors: Bernard Paul BINKS, Russell Elliott, Paul David Ian Fletcher, Andrew James Johnson, Michael Andrew Thompson
  • Publication number: 20140219973
    Abstract: A nanocomposite hydrogel formed from free radical dissociation of an initiator and polymerisation of a water soluble monomer. The resulting hydrogel finds particular application within the medical field for both soft and hard tissue repair in human and animals. The hydrogel is particularly advantageous for spinal disc repair.
    Type: Application
    Filed: August 21, 2012
    Publication date: August 7, 2014
    Inventors: Victoria L. Boyes, Chris Sammon, Christine Lemaitre, Chris Breen
  • Patent number: 8778377
    Abstract: The present invention relates to ceramic precursor material exhibiting injectability and properties that make the material suitable as a carrier material used in drug delivery. According to the invention this is accomplished by selecting a microstructure based on pre-reacted phases and after injection established phases, which contain anti-infective and/or anti-inflammatory drugs. The present invention also relates to a cured ceramic material and a method of manufacturing said cured material. The precursor and the cured ceramic material according to the present invention can suitably be used for filling orthopaedic cavities and other bone voids.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: July 15, 2014
    Assignee: Doxa AB
    Inventors: Leif Hermansson, Håkan Engqvist
  • Patent number: 8741323
    Abstract: To provide An external skin agent that prevents onset of atopic skin inflammations and is low irritant to skin, which is characterized by including: 1) clay modified by a compound having a quaternary amino group; and 2) a polymer or copolymer that has a side chain including a structure similar to a biological component.
    Type: Grant
    Filed: November 25, 2005
    Date of Patent: June 3, 2014
    Assignee: Pola Chemical Industries Inc.
    Inventors: Yasuhiro Ohara, Masashi Suzuki, Norikazu Takano, Shunpei Mitsuyama
  • Publication number: 20140148506
    Abstract: Provided are compositions of various silicone compounds loaded with active pharmaceutical agents, which are suitable for promoting the healing of skin wounds and the reduction or prevention of scarring.
    Type: Application
    Filed: November 14, 2013
    Publication date: May 29, 2014
    Applicant: Allergan, Inc.
    Inventors: Jordan Thompson, Alexei Goraltchouk
  • Patent number: 8729137
    Abstract: A cleansing bar comprising at least one member chosen from clay and talc, wherein a total amount of clay and talc is present in an amount that is greater than any other material in the cleansing bar, at least one cleanser chosen from soap and surfactant, and a binder present in an amount to structure the cleansing bar into a bar.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: May 20, 2014
    Assignee: Colgate-Palmolive Company
    Inventors: Steve Misner, Long Pan, Diana Scala, Regina Hourigan, Ravi Subramanyam, Dennis Fletcher, Patricia Hall-Puzio, Shamim Ansari, Derek Le
  • Publication number: 20140128477
    Abstract: The present invention is directed to immediate release film coating systems for use on oral dosage forms such as compressed tablets and other orally-ingestible substrates which have improved moisture barrier properties. The film coating systems can be applied either directly to a substrate or after the substrate has been coated with a subcoat. In preferred aspects, the moisture barrier film coating is prepared as a dry powder mixture containing polyvinyl alcohol, a polymer with pH dependent solubility, a plasticizer, a glidant, and, optionally, a detackifier, an alkalizing agent and a pigment. Film coating compositions containing an aqueous suspension of the powder mixtures, methods of applying the coatings to substrates and the coated substrates are also disclosed.
    Type: Application
    Filed: January 15, 2014
    Publication date: May 8, 2014
    Applicant: BPSI Holdings, LLC.
    Inventors: Thomas P. Farrell, Jason TECKOE
  • Patent number: 8715724
    Abstract: A process for producing a compressed solid dosage form containing an active ingredient. The process includes a step of preparing core elements containing the active ingredient. Optionally the core elements are coated with a pharmaceutically acceptable coating layer to form coated pellets. The core elements or pellets are treated with an anti-static agent and compressed with suitable excipients to form the compressed solid dosage form. Preferred anti static agents are starch, microcrystalline cellulose, kaolin, bentonite, silicates, silicon dioxide, cellulose, stearic acid, sodium stearyl fumarate and glyceryl behenate.
    Type: Grant
    Filed: October 28, 2005
    Date of Patent: May 6, 2014
    Assignee: Mayne Pharma International Pty Ltd
    Inventor: Stefan Lukas